WHO launches new guide to help scale psychological self-help
1 June 2026 WHO has launched a guide to help countries and organizations scale up psychological self-help interventions, aiming to expand access to...
The Hidden Hotspots: Why Cold-Climate Cities Are Warming Fastest, Threatening Public Health
Health and Medical News Journalist LONDON — A groundbreaking global study analyzing two decades of satellite data from 1,400 cities has overturned...
Can 40 Push-Ups Predict Your Heart Disease Risk? New Research Says Yes
A simple, no-cost fitness test performed a decade ago strongly predicted which middle-aged men would develop cardiovascular disease, according to a...
FDA Approves Novel Antibiotic Zaynich for Complicated UTIs, Weaponizing a New Mechanism Against Superbugs
WASHINGTON — In a major victory for the global fight against antimicrobial resistance, the U.S. Food and Drug Administration (FDA) approved a...
J&J’s Erleada Shows Breakthrough Results in High-Risk Prostate Cancer, Reducing Spread and Death Risk in Landmark Phase 3 Trial
Published: June 2, 2026 | Updated: June 2, 2026 CHICAGO — Johnson & Johnson's prostate cancer medication Erleada (apalutamide), when combined...
